Bionical Emas

Bionical Emas is the only CRO to combine Clinical Development, Early Access Programs and Clinical Trial Supply, to deliver a unique, seamless approach bringing new medicines to patients faster. We build close partnerships with our clients, so we can provide an integrated service, shaped to fit our clients’ needs, ultimately accelerating their drug development programs and supporting them to provide earlier access to medicine for patients.

We bring decades of experience in developing and commercializing medicines at global, regional, and national levels. We provide full service, end-to-end support to drive pharmaceutical and biotech product development.